Arrowstreet Capital’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Arrowstreet Capital’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$9.24M	Buy	+311,631	New	+$8.93M	﹤0.01%	1063
2022 Q2	–	Sell	-31,986	Closed	-$1.98M	–	1302
2022 Q1	$1.98M	Buy	+31,986	New	+$1.96M	﹤0.01%	813
2020 Q3	–	Sell	-63,181	Closed	-$12.5M	–	2394
2020 Q2	$12.5M	Sell	63,181 -13,996	-18%	-$2.9M	0.02%	683
2020 Q1	$15.1M	Sell	77,177 -2,517	-3%	-$542K	0.04%	370
2019 Q4	$16.5M	Buy	+79,694	New	+$14.7M	0.04%	446
2019 Q1	–	Sell	-28,701	Closed	-$2.63M	–	1796
2018 Q4	$2.63M	Sell	28,701 -17,410	-38%	-$1.77M	0.01%	720
2018 Q3	$5.18M	Buy	46,111 +35,086	+318%	+$3.71M	0.01%	504
2018 Q2	$1.02M	Buy	+11,025	New	+$1.07M	﹤0.01%	803
2018 Q1	–	Sell	-38,952	Closed	-$3.65M	–	1201
2017 Q4	$3.65M	Buy	+38,952	New	+$3.68M	0.01%	670
2017 Q3	–	Sell	-2,800	Closed	-$214K	–	1149
2017 Q2	$214K	Buy	+2,800	New	+$236K	﹤0.01%	989

Other funds holding LKFT

Gilead Sciences Foster City, California $1.46B AUM 71.23% 1-Year Est. Return

Prosight Management Dallas, Texas $515M AUM 2.95% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $123B AUM 30.05% 1-Year Est. Return

HRT Financial New York $57.2B AUM 52.85% 1-Year Est. Return

American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Arrowstreet Capital's LKFT Position: Q3 2026 in Review

Arrowstreet Capital opened a new position in Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2026: 311,631 shares worth $9.24M. The stake represents ﹤0.01% of the portfolio and ranks #1063 among its holdings. This is a return to the name: Arrowstreet Capital previously reported a position in LKFT as recently as Q1 2022.

Arrowstreet Capital first reported a position in LKFT in Q2 2017 and has held it in 10 quarters since. The position peaked at $16.5M in Q4 2019. 66 funds tracked by Wall St. Rank hold LKFT as of Q3 2026.

Arrowstreet Capital held 311,631 shares of Lakefront Biotherapeutics American Depositary Shares worth $9.24M as of Q3 2026.
Lakefront Biotherapeutics American Depositary Shares was a new Arrowstreet Capital position in Q3 2026.
Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Arrowstreet Capital's portfolio in Q3 2026, its #1063 holding.
Arrowstreet Capital first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2017 and has held it in 10 quarters since.
Arrowstreet Capital's Lakefront Biotherapeutics American Depositary Shares position peaked at $16.5M in Q4 2019.
66 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2026.

Based on Arrowstreet Capital's 13F filing for Q3 2026, filed 13 Nov 2026.